CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
3.850
-0.450 (-10.47%)
At close: Sep 22, 2026, 4:00 PM EDT
3.800
-0.050 (-1.30%)
Pre-market: Sep 23, 2026, 8:50 AM EDT
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $7.28 million as of September 22, 2026. Its market cap has decreased by -77.25% in one year.
Market Cap
7.28M
Enterprise Value
5.67M
1-Year Change
-77.25%
Ranking
Category
Stock Price
$3.85
ChartMarket Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $7.28M, a decrease of -76.21%. That is a compound annual growth rate of -15.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 5.60M | -68.72% |
| Dec 31, 2025 | 17.90M | -56.55% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
| Jan 31, 2018 | 30.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alzamend Neuro | 9.29M |
| Aprea Therapeutics | 9.01M |
| Imunon | 8.53M |
| Exicure | 8.31M |
| Ensysce Biosciences | 8.30M |
| Soligenix | 8.30M |
| Longeveron | 8.07M |
| Evogene | 8.03M |